Register to use all the features of this website, including selecting clinical areas of interest and “favourite” articles, taking part in quizzes and much more.
Hint: If you are a General Practitioner your username may be your MCNZ#
About us | FAQ | Contact us | Terms of use
Interactive quizzes are based on material found in Best Practice Journal and Best Tests. Initially, quizzes are posted out with journals and GPs are invited to submit their answers for CME credits.
Register or Log in to take part in quizzes.
Login to my bpac.
Don't have an account? Register to use all the features of this website, including selecting clinical areas of interest, taking part in quizzes and much more.
Preventing SARS-CoV-2 infection and managing the acute phase of illness has been the central focus of the New Zealand healthcare... View Article
Measles, mumps and rubella are vaccine-preventable causes of significant morbidity and mortality (particularly for measles), that... View Article
Human Immunodeficiency Virus (HIV) Pre-Exposure Prophylaxis (PrEP) is a daily oral tablet that, when taken as prescribed, can... View Article
Vaccination against human papillomavirus (HPV) infection provides safe and effective protection from genital warts, most cervical... View Article
A new direct-acting antiviral (DAA) oral regimen for the treatment of hepatitis C, glecaprevir + pibrentasvir (Maviret) will be... View Article
Hepatitis C infection occurs through exposure to infected blood or body fluids. The majority of newly acquired infections in New... View Article
Patients should be assessed for cirrhosis via clinical examination, laboratory tests and an APRI score (or liver elastography... View Article
Glecaprevir + pibrentasvir is taken once daily for eight weeks. Headache and fatigue are the most likely adverse effects. HCV... View Article
Dr Tony Farrell is a general practitioner in Mount Maunganui and has a Fellowship in Addiction Medicine. He has a special interest... View Article
Tenofovir disoproxil and entecavir are once daily oral antiviral medicines, recommended as first-line treatments for patients... View Article
Since publication of our article on Zostavax vaccine in March, 2018, we have received feedback from several readers seeking clarification... View Article
Two subsidised seasonal influenza vaccines, Influvac Tetra (for adults and children aged three years and over) and Fluarix Tetra... View Article
Zostavax is a herpes zoster (shingles) vaccine that will become fully subsidised from 1 April, 2018 for people aged 65 years.... View Article
Three new oral medicine regimens for the treatment of hepatitis C, known as directly acting antivirals (DAAs), are fully subsidised... View Article
Valaciclovir is an antiviral medicine which can be used for the treatment of Herpes simplex infections and herpes zoster. As of... View Article